HALO vs JD · P/E 15, rev $857.7M vs P/E 7.6, rev $187.20B
Halozyme Therapeutics Inc (HALO) versus JD.com Inc Adr (JD) — a side-by-side from cached financials, not a winner call.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
HALO currently screens at market cap $7.10B and trailing P/E 15.3. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Not investment advice. Open the HALO and JD stock pages for the full models.
Not investment advice.